KASHEIKA MCNEILL: Open Payments
NPI 1649817016 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 27 payments from 13 companies in 2025. Trend: 2023 $68 · 2024 $455 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $202 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| SCPHARMACEUTICALS INC. | 2 | $66 |
| Novo Nordisk Inc | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Boston Scientific Corporation | 2 | $41 |
| Kestra Medical Technology Services, Inc. | 1 | $40 |
Products named: Barostim Neo System, LEQVIO, FUROSCIX, CAMZYOS, Wegovy, JARDIANCE, VERQUVO, WATCHMAN Access System.
Industry payments across VA — which companies pay providers there.
